ORLOGIN
Neurim Pharmaceuticals (1991) Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78296269 |
| Registration Number | 2969958 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 1 |
| Domestic Representative | BIRCH, STEWART, KOLASCH & BIRCH, LLP |
| Attorney Name | Charles Gorenstein (Reg. No. 29,271) |
| Attorney Docket Number | 4435-0104T |
| Law Office Assigned | M50 |
| Employee Name | BOAGNI, MARY E |
Timeline
| 2003-09-04 | Application Filed |
| 2004-12-21 | Published for Opposition |
| 2005-07-19 | Trademark Registered |
| 2012-03-15 | Cancelled |
| 2012-03-15 | Status: Dead/Cancelled |
| 2012-03-19 | Location: |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Neurim Pharmaceuticals (1991) Ltd. |
| Address | 8 Hanechoshet St. 69710 Tel Aviv IL |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | IL |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of Central Nervous System disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2004-03-08 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION E-MAILED | 2004-03-08 | 2 GNRT F:First Action |
| PAPER RECEIVED | 2004-08-18 | 3 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-08-18 | 4 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2004-09-17 | 5 ACEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2004-09-18 | 6 CNSA P: |
| ASSIGNED TO LIE | 2004-10-04 | 7 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2004-10-15 | 8 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2004-12-01 | 9 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2004-12-21 | 10 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2005-03-15 | 11 NOAM O:Outgoing Correspondence |
| PAPER RECEIVED | 2005-05-09 | 12 MAIL I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2005-05-09 | 13 IUCN S: |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2005-05-25 | 14 DP1B I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2005-07-19 | 15 R.PR A:Allowance for Publication |
| TEAS SECTION 7 SURRENDER RECEIVED | 2012-02-16 | 16 ES7S I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-03-06 | 17 APRE A:Allowance for Publication |
| REQUEST FOR SECT 7 TOTAL SURRENDER FILED | 2012-03-06 | 18 C7RF I:Incoming Correspondence |
| CANCELLED SECTION 7-TOTAL | 2012-03-15 | 19 C7.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ORLOGIN 86685638 not registered Dead/Abandoned |
Neurim Pharmaceuticals (1991) Ltd. 2015-07-07 |
 ORLOGIN 85374936 not registered Dead/Abandoned |
Neurim Pharmaceuticals (1991) Ltd. 2011-07-19 |
 ORLOGIN 78296269 2969958 Dead/Cancelled |
Neurim Pharmaceuticals (1991) Ltd. 2003-09-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 